Sarcoidosis: Immunopathogenesis and Immunological Markers

@article{Loke2013SarcoidosisIA,
  title={Sarcoidosis: Immunopathogenesis and Immunological Markers},
  author={Wei Sheng Joshua Loke and Cristan Herbert and Paul S Thomas},
  journal={International Journal of Chronic Diseases},
  year={2013},
  volume={2013}
}
Sarcoidosis is a multisystem granulomatous disorder invariably affecting the lungs. It is a disease with noteworthy variations in clinical manifestation and disease outcome and has been described as an “immune paradox” with peripheral anergy despite exaggerated inflammation at disease sites. Despite extensive research, sarcoidosis remains a disease with undetermined aetiology. Current evidence supports the notion that the immune response in sarcoidosis is driven by a putative antigen in a… Expand
Potential use of biomarkers for the clinical evaluation of sarcoidosis
TLDR
A diagnosis of sarcoidosis ideally requires a biopsy confirming non-caseating granulomas, but the likelihood of progression that requires intervention remains unpredictable, and challenging aspects could be potentially resolved by incorporating biomarkers into clinical practice for both diagnosis and monitoring disease activity. Expand
Serological biomarkers of granuloma progression in sarcoidosis
TLDR
Common serological markers are overviewed, including angiotensin converting enzyme (ACE) and lysozyme, and new promising indices in sarcoidosis such as a T cell serological marker (soluble interleukin 2 receptor; sIL-2R) and thymus and activation-regulated chemokine (TARC/CCL17). Expand
Sarcoidosis: a state of the art review from the Thoracic Society of Australia and New Zealand
TLDR
The current understanding of sarcoidosis is outlined, and whole body positron emission tomography scanning has improved localisation of disease, but no single biomarker is adequately sensitive and specific for detecting and monitoring disease activity. Expand
MicroRNAs in pulmonary sarcoidosis: A systematic review.
TLDR
This systematic review summarizes the current information on miRNAs in sarcoidosis, the biological mechanisms involved in CD4+ T-helper 1 and macrophage polarization, and the use of exhaled breath condensate as an alternative, noninvasive and potential source of miRNAAs. Expand
Sarcoidosis: Role of non-tuberculosis mycobacteria and Mycobacterium tuberculosis.
TLDR
Observations suggest that TB and sarcoidosis may not only share the same etiology, but may even be different aspects of one disease. Expand
Sarcoidosis as an Autoimmune Disease
TLDR
This review attempts an integral analysis of currently available information suggesting an autoimmune genesis of sarcoidosis and is divided into four categories: the evaluation of clinical signs described both in patients with sarcoIDosis and “classic” autoimmune diseases, the role of triggering factors in the development of sarCOidosis, the presence of immunogenic susceptibility in theDevelopment of the disease, and the analysis of cellular and humoral immune responses in sarcoids. Expand
Interleukin-12 family cytokines and sarcoidosis
TLDR
This review will discuss the current understanding of etiology and immunopathogenesis of sarcoidosis with a specific focus on the bidirectional impact of IL-12 family cytokines on the pathogenesis of SARCOidosis. Expand
Sarcoidosis from Head to Toe: What the Radiologist Needs to Know.
TLDR
Computed tomography (CT), magnetic resonance imaging, and positron emission tomography/CT are useful in the diagnosis of extrapulmonary sarcoidosis, but imaging features may overlap with those of other conditions. Expand
Emerging and potential treatment options for sarcoidosis
TLDR
Future advances in the care of sarcoidosis will involve therapy of specific problematic phenotypes, treatment of non-granulomatous aspects of the disease, development of pharmacogenetics techniques and biomarkers to personalize care and further focus on quality of life issues endpoints to make treatment decisions. Expand
EPIDEMIOLOGY OF SARCOIDOSIS IN THE RUSSIAN FEDERATION
TLDR
Analysis of publications on the epidemiology of sarcoidosis over the past 40 years has shown that, despite the heterogeneity of the data, there is a general tendency of increase in the incidence and prevalence of sarCOidosis. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 206 REFERENCES
Sarcoidosis—scientific progress and clinical challenges
TLDR
There are no clinically useful biomarkers that can assist the clinician in diagnosis, prognosis or assessment of treatment effects, and the role of immunosuppressive drugs and anti-TNF agents in the treatment of sarcoidosis remains uncertain. Expand
Etiology of Sarcoidosis: Does Infection Play a Role?
TLDR
The known histologic and immunologic features of sarcoidosis are described and the evidence supporting a role for infectious processes in the pathogenesis of sarCOidosis is discussed. Expand
Sarcoidosis
TLDR
Several new insights have been made, particularly with regards to the diagnosis and care of some important manifestations of sarcoidosis, and the elucidation of relevant biomarkers, reliable endpoints, and new efficient treatments are predicted. Expand
Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics.
TLDR
While the etiology of sarcoidosis is still unknown, recent insights into its immunopathogenesis have moved investigators closer to finding more effective treatments. Expand
Sarcoidosis: immunology, rheumatic involvement, and therapeutics.
TLDR
Medical vigilance, with attention to new patient symptoms, is important in the management of sarcoidosis, because of the tendency of this disease to present in so many and diverse patterns. Expand
Immunologic response of sarcoidosis.
TLDR
The complex immunological events and immune effector cells that are critical to the induction, evolution, and resolution of the sarcoid granulomatous response are discussed. Expand
Update on sarcoidosis.
TLDR
The local inflammatory response in sarcoidosis appears to be a Th1-mediated process, evidence exists that the systemic immune response, however, shows a Th2 predominance, and evidence for a possible role for human herpesvirus 8 is submitted. Expand
Evidence for mycobacteria in sarcoidosis.
TLDR
The result of these efforts indicates that mycobacterial products likely play a role in at least a subset of sarcoidosis cases, and a better understanding of genetic susceptibility to this complex disease has therapeutic implications. Expand
The etiologic role of infectious antigens in sarcoidosis pathogenesis.
TLDR
The recent progress of independent laboratories, using complementary techniques, strengthens the role of microbial antigens in sarcoidosis pathogenesis and lays a strong foundation toward identifying therapeutic targets. Expand
The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.
TLDR
Elucidating the natural history of sarcoidosis-associated PF will inform the understanding of the fundamental derangements, and will enhance prognostication and the development of therapeutic strategies. Expand
...
1
2
3
4
5
...